Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,457–1,464 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Delcath Systems Inc. HEPZATO Liver-Dominant Metastatic Breast Cancer Phase 2 IND Clearance Intra-arterial Oncology
Delcath Systems Inc. HEPZATO Liver-Dominant Metastatic Colorectal Cancer Phase 2 Enrollment Initiation Intra-arterial Oncology
Denali Therapeutics Inc. BIIB122 - (LUMA) Parkinson's disease Phase 2b Ongoing Oral Neurology
Denali Therapeutics Inc. DNL758 (SAR443122) Cutaneous lupus erythematosus Phase 2 Trial Completed oral Immunology
Denali Therapeutics Inc. BIIB122 (DNL151) - (LIGHTHOUSE) Parkinson's Disease Associated with LRRK2 Pathogenic Mutations Phase 3 Oral Neurology
Denali Therapeutics Inc. DNL788 (SAR443820) - (HIMALAYA) Amyotrophic lateral sclerosis (ALS) Phase 2 Oral Neurology
Denali Therapeutics Inc. DNL758 (SAR443122) Cutaneous lupus erythematosus Phase 2 Trial Completed oral Immunology
Denali Therapeutics Inc. DNL788 (SAR443820) - (HIMALAYA) Amyotrophic lateral sclerosis (ALS) Phase 2 Oral Neurology